About Cortex
Cortex is a company based in Santa Clara (United States) founded in 2023 was acquired by Boston Scientific in November 2024. It operates as a HealthTech. Cortex offers products and services including OptiMap System. Cortex operates in a competitive market with competitors including Kardium, Argá Medtech, Adagio Medical, Farapulse and Affera, among others.
- Headquarter Santa Clara, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Boston Scientific
(Nov 04, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cortex
Cortex offers a comprehensive portfolio of products and services, including OptiMap System.
Electrographic flow mapping system for atrial fibrillation treatment.
Funding Insights of Cortex
Detailed funding history for Cortex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cortex
Cortex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wide range of medical devices
|
Locked | Locked | Locked |
Investor details for Cortex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cortex
Investment portfolio details for Cortex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cortex
Detailed financials for Cortex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cortex Comparisons
Peer comparison for Cortex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cortex
Cortex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kardium, Argá Medtech, Adagio Medical, Farapulse and Affera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Atrial fibrillation ablation devices are developed by Kardium.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac arrhythmias are developed by Argá Medtech.
|
|
| Locked | Locked | Locked |
Cardiovascular therapies are developed by Adagio Medical in stealth mode.
|
|
| Locked | Locked | Locked |
Devices for cardiac ablation via pulsed field technology are developed.
|
|
| Locked | Locked | Locked |
Devices for treating heart rhythm disorders are developed.
|
|
| Locked | Locked | Locked |
Pulsed electric field ablation devices for heart arrhythmias are developed.
|
Detailed competitors of Cortex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cortex
Complete news archive for Cortex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cortex
Cortex was founded in 2023.
Cortex is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Duke Rohlen is the current CEO of Cortex.
Cortex is engaged in developing innovative solutions for the diagnosis and treatment of atrial arrhythmias. The company specializes in electrographic flow (EGF) mapping technology through its OptiMap System, which is designed to visualize and personalize treatment for atrial fibrillation. By leveraging AI and advanced algorithms, Cortex aims to optimize clinical outcomes in the cardiovascular sector, particularly for complex cases where standard approaches are insufficient. Their solutions are integrated into medical workflows to support physicians in identifying critical triggers and drivers of arrhythmias.
Cortex's top competitors include Kardium, Adagio Medical and Field Medical.
Cortex offers OptiMap System.
Cortex has 1 investor. Key investors include Boston Scientific.